IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RHO Capital Partners Inc

Q4 2019 Holdings

Filed 2020-02-13 | 5 holdings | $131.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$69.6K3,766,66652.9%
Cara Therapeutics Inc(CARAEUR)COM140755109$51.4K3,193,05739.1%
Livexlive Media IncCOM NEW53839L208$5.8K3,724,1384.4%
Mersana Therapeutics IncCOM59045L106$4.6K796,4583.5%
Senseonics Hldgs Inc(SENS1GBP)COM81727U105$146159,6010.1%